Freenome, Inc. (FRNM) ROE
- 2026-06-30: ROE 12.11%.
- 2026-03-31: ROE -1.89%.
- 2025-12-31: ROE -17.46%.
- 2025-09-30: ROE -82.00%.
Complete source-backed roe history.
- Available history
- 2025-06-30 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | 12.11% |
| 2026-03-31 | -1.89% |
| 2025-12-31 | -17.46% |
| 2025-09-30 | -82.00% |
| 2025-06-30 | -111.15% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -17.46% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |